Establishing premise: a prep epidemiology, modeling, and surveillance system
Active Project Grant Awarded Last action
- Award ID
- R01AI181799
- Recipient
-
Emory University UEI S352L5PJLMP8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,974,532
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date 46% complete
- Place of performance
- Atlanta, GA 30322, USA
Award details come from USAspending.gov.
Description
- Abstract
- To reach ending the epidemic (ETE) targets, we will need consistent national HIV pre-exposure prophylaxis (PREP) data to describe patterns of use, and to understand which programs and policies are effective at facilitating PREP uptake. Our team has used national PREP prescription datasets that combine diverse sources in order to better understand how PREP is being brough to scale. National prescription datasets are robust and capture a great deal of data. We propose to develop the premise (PREP epidemiology, modeling, and surveillance) group that will use national PREP data, along with legal and policy coding, to inform the US HIV epidemic response. Legal and program environments in which individuals initiate PREP are highly heterogeneous, yet evidence regarding which policies lead to improved outcomes is lacking. Our past work demonstrated a substantial association between PREP use and the presence of PREP drug assistance programs. ETE programs have expended considerable resources in HIV prevention promotion programming. Natural experimental designs can provide evidence regarding PREP uptake in light of such programs. Such analyses require developing nuanced datasets of policies and programs. Our team has extensive experience in both PREP program and policy data collection, allowing for rigorous assessment. The study will conduct analyses regarding the scope and equity of PREP scaleup over time, and will perform analyses to explore the impact of different locality-specific programs and policies on PREP starts and PREP equity. We will use modeling and cost-effectiveness analyses to contextualize findings and facilitate dissemination
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $1,030,884 | |
| Amendment | $1,032,248 | |
| Original award | $911,400 |
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| National Alliance Of State & Territorial Aids Directors | $62,810 | |
| Regents Of The University Of Minnesota | $25,324 | |
| Oregon Health & Science University | $32,304 | |
| National Alliance Of State & Territorial Aids Directors | $61,607 | |
| Oregon Health & Science University | $32,304 | |
| Regents Of The University Of Minnesota | $55,795 | |
| Simon Fraser University | $51,894 | |
| Regents Of The University Of Minnesota | $49,884 | |
| Oregon Health & Science University | $28,883 | |
| National Alliance Of State & Territorial Aids Directors | $166,550 |
Quick answers
Who received award R01AI181799?
R01AI181799 was awarded to Emory University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 14, 2024.
How much is award R01AI181799 worth?
$2,974,532 has been obligated on R01AI181799.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award